Milestone scientific secures key patent approvals in the u.s. and europe

Roseland, n.j., july 30, 2024 (globe newswire) -- milestone scientific inc. (nyse: mlss), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced receipt of multiple notices of allowance (noa) for essential patent applications in both the u.s. and europe.

MLSS Ratings Summary

MLSS Quant Ranking